Summary

Location
at San Francisco, California and other locations
Dates
study started

Description

Summary

This is an expanded access designed to provide access to Relatlimab for eligible participants.

Keywords

Relatlimab

Locations

  • Local Institution not accepting new patients
    San Francisco California 94143 United States
  • Local Institution not accepting new patients
    Hays Kansas 67601 United States

Details

Status
not accepting new patients
Start Date
Sponsor
Bristol-Myers Squibb
Links
BMS Clinical Trial Information BMS Clinical Trial Patient Recruiting Pre-approval Access (PAA) Healthcare Practitioner Requests FDA Safety Alerts and Recalls
ID
NCT05170659
Study Type
Expanded Access
Last Updated